Version history
Lung Nodule Follow-up Guide
70
ASO score
Text
90/100
Reviews
50/100
Graphic
60/100
Other
0/100
App Rating
4.1
Votes
117
App Age
13y 7m
Last Update
Dec 01, 2025
iAP
$17.99 - 22.99
Compare with Category Top Apps
|
Metrics
|
Current App
|
Category Top Average
|
Difference
|
|---|---|---|---|
|
Rating
|
4.17
|
4.6
|
-9%
|
|
Number of Ratings (Voted)
|
116
|
65.1K
|
-100%
|
|
App Age
|
13y 7m
|
9y 2m
|
+47%
|
|
In-app Purchases Price
|
$17
|
$35
|
-50
%
|
|
Update Frequency
|
28d
|
100d
|
-72%
|
|
Title Length
|
27
|
26
|
+4%
|
|
Subtitle Length
|
28
|
26
|
+8%
|
|
Description Length
|
3 636
|
2 634
|
+38%
|
|
Number of Screenshots
|
1404
|
1382
|
+2
%
|
|
Size
|
62MB
|
249MB
|
-75
%
|
Category Ranking in United States
7 days
Last 7 days
Last 30 days
Last 90 days
Last 180 days
Last year
| Top | Dec 23, 2025 | Dec 30, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 23, 2025 | Dec 30, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 23, 2025 | Dec 30, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 23, 2025 | Dec 30, 2025 |
|---|---|---|
|
No results were found!
|
||
Ranking Keywords in United States
| Keywords | App Rank |
|---|
Analyze this and other apps using Asolytics tools
Text ASO
Title
(
Characters:
27
of 30
)
Lung Nodule Follow-up Guide
Subtitle
(
Characters:
28
of 30
)
Lung-RADS v2022 / Fleischner
Description
(
Characters:
3636
of 4000
)
Download includes a free trial; continued use requires a 6‑ or 12‑month auto‑renewing subscription.
Lung Nodule Follow-up Guide is a clinical decision-support guide that streamlines the evaluation and management of lung nodules discovered incidentally or through screening. Built on the Fleischner Society Guidelines 2017 and ACR Lung-RADS v2022, including the latest "S" modifier for clinically significant incidental findings, the app provides clear, step-by-step guidance at the point of care. Whether you're in radiology, pulmonology, or primary care, Lung Nodule Follow-up Guide helps you apply standardized recommendations with clarity and consistency.
---
Key Features (unlocked after the free trial with an active subscription)
Fleischner Society Guideliens 2017 Integration
• Structured recommendations for both solid and sub-solid (non-solid and part-solid) nodules—based on nodule size, nodule attenuation, whether solitary or multiple, and patient-specific risk factors.
ACR Lung‑RADS v2022 Integration
• Full, in‑app access to every Lung‑RADS category (0–4X) plus the “S” modifier, with concise management instructions drawn directly from the guidelines.
Dynamic Lung‑RADS Card
• A single, color‑coded card that updates your Lung‑RADS score in real time as you enter screening round, nodule morphology, size, and growth—making classification fast.
S Modifier Integration
• Toggle clinically significant findings across organ systems (e.g., coronary calcium, thyroid nodule, liver lesion) and instantly receive tailored, ACR‑based follow‑up recommendations sourced from the ACR Incidental Findings White Papers.
Common Issues Insights
• Provides literature-backed guidance on frequently encountered challenges in managing lung nodules—whether incidental or identified through lung cancer screening. Covers key topics such as accurate nodule measurement, interpretation of modifiers, and stepwise management strategies, helping clinicians apply guidelines with precision and consistency.
Self-Assessment Mode
• Expert-curated self-assessment question packs.
Brock (Full Model) Calculator
• Calculate a CT-detected nodule’s 2–4 year malignancy risk.
Enhanced Readability
• Dark‑mode support, dynamic text sizing, and a distraction‑free interface optimized for hectic reading environments.
Offline Access
• All guideline logic run on‑device—no login or server needed.
Medical Disclaimer: This app is for informational purposes only and is not a substitute for professional medical advice. In addition to using this app, always consult a qualified healthcare provider for diagnosis and treatment decisions.
SUBSCRIPTION OPTIONS ¹
• 6‑Month subscription (free trial available) | Price displayed in‑app; may vary by region
• 12‑Month subscription (free trial available) | Price displayed in‑app; may vary by region
We strive to incorporate any updates to ACR Lung‑RADS or S Modifier guidance within 30 days of publication and plan to add new self‑assessment question packs every six months.
Future feature additions and update frequency may change without notice.
¹ Payment & Renewal – Payment is charged to your Apple ID at confirmation. Subscriptions renew automatically unless auto-renew is turned off at least 24 hours before the end of the current period. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions.
Note: If you switch plans or re-subscribe during the free trial, the remaining trial time is lost and you will be charged immediately.
Privacy Policy: https://radiologiq.squarespace.com/privacy
Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/}
Read more
Other
Additional Information
Version history
8.2
Dec 01, 2025
Version 8.2
• Added new self-Assessment quiz pack
Version 8.1.2
• UI/UX refinements (optimized for iOS 26)
Version 8.1.1
• General improvements (e.g. enhanced support for smaller devices)
Version 8.1
• Added Brock (full model) calculator
• Added FAQ section
What's New in Version 8.0
v8.0 is our first major update in six years, bringing Lung Nodule Follow-up Guide up to Lung-RADS v2022 standards. To support ongoing maintenance, regular guideline updates, and self-assessment question packs, this release introduces a free trial—after which continued use requires a 6- or 12-month auto-renewing plan.
Guideline Upgrades
• Upgraded from ACR Lung-RADS v1.1 to ACR Lung-RADS v2022, ensuring you have the latest criteria for lung cancer screening. Added ‘S’ modifier integration for clinically significant incidental findings—instantly flag and address other notable abnormalities.
Smarter Decision Support
• Expert‑curated self‑assessment question packs.
Complete rebuild
• Re‑engineered from the ground up for smoother interaction and greater reliability. Brand‑new modern interface optimized for both iPhone and iPad. Full Dark Mode and Dynamic Type support for comfortable viewing in any environment.
Pricing update
• After the free trial, continued use requires a 6‑ or 12‑month auto‑renewing subscription. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions.
Thanks for using Lung Nodule Follow-up Guide! Tap Settings ▸ Share Your Feedback to let us know how we can keep improving.
Download includes a free trial; continued use requires a 6- or 12-month auto-renewing subscription.
8.1.2
Nov 17, 2025
Version 8.1.2
• UI/UX Refinements (Optimized for iOS 26)
Version 8.1.1
• General improvements (e.g. enhanced support for smaller devices)
Version 8.1
• Added Brock (full model) Calculator
• Added FAQ section
What's New in Version 8.0
v8.0 is our first major update in six years, bringing Lung Nodule Follow-up Guide up to Lung-RADS v2022 standards. To support ongoing maintenance, regular guideline updates, and self-assessment question packs, this release introduces a free trial—after which continued use requires a 6- or 12-month auto-renewing plan.
Guideline Upgrades
• Upgraded from ACR Lung-RADS v1.1 to ACR Lung-RADS v2022, ensuring you have the latest criteria for lung cancer screening. Added ‘S’ modifier integration for clinically significant incidental findings—instantly flag and address other notable abnormalities.
Smarter Decision Support
• Expert‑curated self‑assessment question packs.
Complete rebuild
• Re‑engineered from the ground up for smoother interaction and greater reliability. Brand‑new modern interface optimized for both iPhone and iPad. Full Dark Mode and Dynamic Type support for comfortable viewing in any environment.
Pricing update
• After the free trial, continued use requires a 6‑ or 12‑month auto‑renewing subscription. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions.
Thanks for using Lung Nodule Follow-up Guide! Tap Settings ▸ Share Your Feedback to let us know how we can keep improving.
Download includes a free trial; continued use requires a 6- or 12-month auto-renewing subscription.
